Showing 1931-1940 of 23132 results for "".
CRC Screening Strategies: Balancing Accuracy, Access, and Adherence
https://reachmd.com/programs/on-the-frontlines-of-colorectal-cancer/crc-screening-strategies-accuracy-access-adherence/49177/Our approach to colorectal cancer screening continues to evolve, but questions around real-world adherence and patient access remain. Ryan Quigley sits down with Dr. Samuel Muench, a board-certified gastroenterologist at Capital Digestive Care in Maryland and Washington, DC, to review the strengthsModernizing Pulmonary Assessment: Reassessing Race-Neutral Interpretation in Practice
https://reachmd.com/programs/project-oncology/modernizing-pulmonary-assessment-reassessing-race-neutral-interpretation-in-practice/39036/As medicine shifts toward race-neutral lung function interpretation, new challenges emerge in ensuring equitable access to care. Dr. Ajay Sheshadri explores how race-neutral spirometry may impact patient selection for lung resection surgery and hematopoietic cell transplantation. Dr. SheshadrAlbuterol-Budesonide Rescue for Asthma: MANDALA Safety and Use Patterns
https://reachmd.com/programs/Audioabstracts/albuterol-budesonide-rescue-asthma-mandala/54186/A recent analysis from the MANDALA trial explores patterns of use and safety of as-needed albuterol-budesonide rescue therapy in adults with moderate-to-severe asthma receiving maintenance treatment. Tune in to learn how patients used their rescue inhaler in the study and what these findings may meaAsthma Immunotherapies: Endotypes, Mechanisms, and Emerging Frontiers
https://reachmd.com/programs/Audioabstracts/immunotherapies-asthma-endotypes-mechanisms/54180/Distinct immune pathways in T2high and T2low asthma are shaping more precise therapies. To learn more, tune in as Ryan Quigley explores how endotype insights are guiding current and emerging immunotherapy strategies.Advancing Endometrial Cancer Care: Molecular Targets and Emerging Therapies
https://reachmd.com/programs/project-oncology/endometrial-cancer-molecular-target-therapies/39933/Our approach to treating of endometrial cancer is rapidly evolving beyond traditional immunotherapy and towards cellular therapies, bispecifics, and antibody-drug conjugates. Hear from Dr. Casey Cosgrove as he shares expert insights on the latest developments. Dr. Cosgrove is an Assistant ProfessorUnderstanding Antibody-Mediated Demyelinating Diseases: Key Differences From MS
https://reachmd.com/programs/neurofrontiers/understanding-antibody-mediated-demyelinating-diseases-key-differences-from-ms/32821/Antibody-mediated demyelinating diseases, such as neuromyelitis optica spectrum disorder and MOG antibody disease, differ fundamentally from multiple sclerosis (MS) due to their association with specific antibodies. Dr. Michael Levy explains how these conditions progress, how relapses can driNavigating Iron Deficiency Anemia: A Practical Guide for Gastroenterologists
https://reachmd.com/programs/gi-insights/program-name/36501/Iron deficiency anemia is common in gastroenterology patients and is often underrecognized or suboptimally managed. That's why targeted treatment is essential to improve patient outcomes. In this expert-led discussion, Dr. Peter Buch and Dr. Thomas DeLoughery outline what gastroenterologists need tEvolving Strategies in Limited-Stage Small Cell Lung Cancer Management
https://reachmd.com/programs/deep-breaths-updates-chest/evolving-strategies-in-limited-stage-small-cell-lung-cancer-management/32963/Recent therapeutic advances are reshaping our approach to limited-stage small cell lung cancer. In this multidisciplinary discussion, Dr. Gerard Silvestri sits down with Drs. Adam Fox, Mariam Alexander, and Anurag Singh to explore the evolving standard of care and practical considerations for timelyAdvances in MS Management: Current and Future Directions
https://reachmd.com/programs/neurofrontiers/advances-in-ms-management-current-and-future-directions/26387/Read about a recent review article that provided critical insights on the pathophysiology, diagnosis, and treatment of multiple sclerosis.Metabolomics in Multiple Sclerosis: Advancing Diagnosis, Prognosis, and Treatment Response
https://reachmd.com/programs/neurofrontiers/metabolomics-in-multiple-sclerosis-advancing-diagnosis-prognosis-and-treatment-response/32373/Learn about recent research on metabolomics in multiple sclerosis and potential applications in patient care.